UAB MIP Pharma Lietuva Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Working capital requirement |
Debt-to-equity ratio |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
100,994 |
100,994 |
79,371 |
73,548 |
73,548 |
0.84 |
0.08 |
99.93 |
72.82 |
85,300 |
6,450 |
0 |
92,390 |
2023 |
---|
30,931 |
30,931 |
20,251 |
19,340 |
19,340 |
3.38 |
0.01 |
99.84 |
62.53 |
104,641 |
1,558 |
0 |
106,839 |
2024 |
---|
38,176 |
38,176 |
29,607 |
28,275 |
28,275 |
3.48 |
0.05 |
99.92 |
74.06 |
132,916 |
6,326 |
0 |
139,882 |
Register and
explore Okredo data2024 |
---|
38,176 |
38,176 |
29,607 |
28,275 |
28,275 |
3.48 |
0.05 |
99.92 |
74.06 |
132,916 |
6,326 |
0 |
139,882 |
Register and
explore Okredo data2024
Turnover (€)
38,176 €23 % *
Sales per employee (€)
38,176 €23 % *
Profit before tax (€)
29,607 €46 % *
Net Profit (€)
28,275 €46 % *
Profit per employee (€)
28,275 €46 % *
Working capital requirement
3.48 2.96 % *
Debt-to-equity ratio
0.05 400.00 % *
Total profitability (%)
99.92 %0.08 % *
Net profitability (%)
74.06 %18.44 % *
Equity (€)
132,916 €27 % *
Amounts Payable And Liabilities (€)
6,326 €306 % *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
139,882 €31 % *